FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical industry and represents a preparation possessing the anti-inflammatory action, stimulating the mucosa regeneration, and containing magnesium-chloride mineral bischofit brine 1.27±0.01 g/ml with normalised specific gravity, slastiline, menthol, thymol, and a stabilising agent differing by the fact that it contains magnesium-chloride mineral bischofit brine free from technogenic impurities, with the ingredients in the preparation are taken in specific proportions, g.
EFFECT: reducing acute daily oral toxicity in 1,7-1,9 times.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR BISCHOFITE PURIFICATION | 2007 |
|
RU2442593C2 |
BALNEOLOGICAL MEAN BASED ON CRYSTALLINE BISCHOFITE | 2015 |
|
RU2657570C2 |
PROLONGED LIQUID DOSAGE FORM OF BISCHOFITE | 2011 |
|
RU2455008C1 |
BISCHOFITE DOSAGE FORM FOR TREATING PYOINFLAMMATORY PROCESSES OF MUCOSAE AND SKIN | 2011 |
|
RU2469705C1 |
IODINATED MAGNESIUM CHLORIDE | 2009 |
|
RU2417089C2 |
PURGATIVE AGENT | 1992 |
|
RU2078569C1 |
COMBINED METHOD FOR CLEANING NATURAL BISCHOFITE BRINE | 2016 |
|
RU2643047C2 |
METHOD FOR CLEANING BISCHOFITE FROM IRON COMPOUNDS | 2020 |
|
RU2748371C1 |
DOCTOR RUSTAMOV'S OINTMENT | 2013 |
|
RU2527335C1 |
9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
Authors
Dates
2014-01-27—Published
2013-01-09—Filed